Consolidation with alemtuzumab in patients with chronic lymphocytic leukemia (CLL) in first remission – experience on safety and efficacy within a randomized multicenter phase III trial of the German CLL Study Group (GCLLSG)

✍ Scribed by Wendtner, C-M; Ritgen, M; Schweighofer, C D; Fingerle-Rowson, G; Campe, H; Jäger, G; Eichhorst, B; Busch, R; Diem, H; Engert, A

• Book ID: 110055880
• Publisher: Nature Publishing Group
• Year: 2004
• Tongue: English
• Weight: 134 KB
• Volume: 18
• Category: Article
• ISSN: 0887-6924
• DOI: 10.1038/sj.leu.2403354